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Abstract 
Crimean-Congo hemorrhagic fever (CCHF) is a severe viral disease with high fatality rate. 
CCHF virus is endemic in parts of Africa, Asia, Middle East and southeastern Europe. 
Rapid diagnostics of CCHF is vital for appropriate clinical management and prevention of 
secondary spread from human-to-human. Currently, diagnostics relies on Real-Time RT-
PCR and antibody or antigen detection using ELISA. These methods require trained 
personnel and expensive equipment and are not appropriate for point-of-care (POC) 
diagnostics. Furthermore there are no POC assays available for CCHF. 
We developed a fiber-optic biosensor for the detection of CCHF IgG antibodies. In order 
to improve sensitivity, we optimized both the bioreceptor immobilization protocol and 
the chemiluminescence substrate formulation. The resulting protocol showed a 100-fold 
greater sensitivity for detection of CCHF antibodies. Finally, we evaluated the fiber-optic 
biosensor with two CCHF patient sera. We showed that the fiber-optic biosensor is 10-
times more sensitive that colorimetric ELISA and is able to detect both patients with 
high and low levels of IgG antibodies. We believe that the fiber-optic biosensor is a 
suitable alternative to ELISA as it is much more sensitive and makes it possible to detect 
small amount of antibodies at an early stage of infection, and can be integrated as a 
point-of-care diagnostic system of CCHF. 
 
Introduction 
Crimean-Congo hemorrhagic fever (CCHF) is a severe viral disease with an average case 
fatality rate of 5-30%. CCHF virus is the most widespread tick-borne virus in the world, 
with cases reported from Africa, Middle East, Asia, Russia and southeastern Europe. The 
virus is transmitted to humans mainly by infected ticks from the genus Hyalomma or by 
contact with blood or tissues from infected humans and animals. CCHF virus is classified 
as a BSL-4 agent due to its high pathogenicity, possibility of spread from human to 
human and because there is no effective treatment or vaccine available [1]. Rapid 
diagnostics are essential for effective infection control and prevention of spread of the 
disease from human to human. Namely, healthcare professionals are at high risk of 
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infection due to their close contact with patients especially during invasive and aerosol-
forming interventions and many nosocomial transmissions have been reported 
1
. 
Quick diagnostics provide the basis for the implementation of proper infection control 
measures and patient management 
2–4
. Currently the diagnostics of acute CCHF relies 
mainly on the detection of viral RNA with Real-Time RT-PCR. This method enables quick, 
sensitive and specific detection, but is not suitable for point of care (POC) diagnostics, as 
it requires trained personnel and expensive equipment 
5,6
. Besides, these criteria are 
mostly not met in rural areas where CCHF is endemic 
7
. Diagnostics of acute CCHF is also 
performed with ELISA for detection of IgG and IgM antibodies as well as CCHF virus 
nucleoprotein (NP) and rarely by virus isolation. Current serological assays provide 
reliable results and offer adequate sensitivity in clinical settings, however they all 
require trained personnel, are time consuming and not appropriate for POC diagnostics 
7
. An ideal POC test for detection of CCHF IgG would have to exhibit sensitivity and 
specificity similar to or greater than the current sensitivity and specificity of standard in-
house and commercial ELISA tests that ranges between 66.9–90.2% and 95.8–100.0% 
respectively
 5
.  Besides it would ideally give quantitative results, be easy to use, robust 
and offer maximum operational safety to the user. 
There is a need for point-of-care diagnostic assays allowing for quick and reliable, 
bedside diagnostics of CCHF. Fiber-optic biosensors present a suitable alternative to 
existing diagnostic options for CCHF due to their small size, diagnostic accuracy and low 
cost. Other POC technologies, such as lateral flow have similar advantages however they 
do not give quantitative results and have limited multiplexing capabilities. Optic fiber 
biosensors are quantitative and can easily be multiplexed, a feature that would enable 
the design of a multiple-target POC assay. The core of optic-fiber biosensor 
development is the immobilization of capture affine biomolecules (eg. antigen, 
antibodies, nucleic acids) at the endface and the tip of an optical fiber. Target molecules 
then bind to the capture biomolecules and these can also bind to complementary 
labeled detection biomolecules. After exposure to a substrate, the marker enzyme 
oxidizes it and a chemiluminescent glow is produced as a side reaction that is collected 
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by the optical fiber and transduced to the detector 
8
. Previously we developed fiber-
optic biosensors for sensitive detection of antibodies against Ebola virus, Rift Valley 
Fever virus, Dengue virus, West-Nile and Hepatitis C 
9–13
. The aim of this study is to 
develop a fiber-optic biosensor for accurate detection of antibodies against CCHF virus 
NP and to optimize the fiber-optic immobilization procedures so as to enhance overall 
signal.  
 
 
Materials and methods  
Materials 
Methyl alcohol (136805) was purchased by Bio-Lab (Israel), acetic acid (45731, 99.8% 
(v/v)) was purchased from Fluka, sulfuric acid (76649390, 95% (v/v)), hydrochloric acid 
(7647010, 37% (v/v)) and hydrogen peroxide solution (7722841, 35%(v/v)) were 
purchased from Acros Organic (USA). 3-(Glycidoxypropyl)trimethoxysilane 
(GPTMS)(440167, 98%(v/v)), sodium m-periodate (S1878), phosphate buffer saline 
(PBS)(P4417), sodium cyanoborohydride (71435), glycine (G7403), skim milk powder 
(SM)(70166), Luminol (A8511), 4-morpholinopyridine (MORP) (480657) and 
polyoxyethylene-sorbitan monolaurate (Tween® 20) (P7949) were purchased from 
Sigma Aldrich (Israel).  
 
CCHFV-N protein expression and purification 
For expression 1-50ng of plasmid CCHFNhispET19# (provided by Ali Mirazimi) containing 
the nucleocapsid gene of CCHFV strain Ibr10200 was transformed into BL21 and plated 
out for overnight culture on LB amp plates at 37°C. Clones were picked and 
subsequently cultured overnight in 5ml LB amp at 37°C, 50ml LB amp culture for 24h at 
28°C after transfer of 1 ml, and 500ml LB amp culture after transfer of 10 ml at 28°C 
during the following day until an OD260nm between 0.4-0.6 was reached (NanoDrop). 
Expression was induced with 1 mM IPTG and the culture continued at 28°C overnight. A 
bacterial pellet was harvested by centrifugation at 4000g / 20min, washed with PBS, 
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resuspended im 5ml buffer A2, disrupted at level 3.5 (Sonifier II W-250/W-450, Branson, 
USA) for 30 sec for 7 times on ice and finally centrifuged at 12.000g, 4°C for 25 min. The 
supernatant was transferred to equilibrated Ni-agarose (1.4ml Ni-agarose (Qiagen, 
Germany) washed twice with 10ml water and twice with buffer A1) and incubated for 2h 
at 4°C on a shaker. After one additional centrifugation step the agarose was 
resuspended in 1ml buffer A1 and transferred into an empty column (Biorad, Germany). 
The column was then successively washed with 20ml buffer B, 10ml buffer E1, and the 
protein was eluted with 8 fractions of 500µl buffer E2. (Buffer A (50 mM Tris (pH 8,0), 
500 mM NaCl , 5 mM MgCl , 10 % Glycerin, 0,1 % NP-40, 2mM Imidazol), buffer A1 
(bufferA + 140mM ß-mercaptoethanol), buffer A2 (BufferA + 0.1mM PMSF), buffer B  
(buffer A1 + 28mM Imidazol), elution buffer E (20 mM Tris (pH 8.0), 100 mM NaCl, 5 mM 
MgCl, 20 % Glycerin), buffer E1 (buffer E, 2mM Imidazol), buffer E2 (buffer E, 250mM 
Imidazol). The protein concentration was determined by the Bradford method (BCA-
Assay, Pierce, UK) after confirming a pure band on an SDS page-gel. 
 
CCHF sera and antibodies 
Inactivated sera from two confirmed CCHF cases, CCHFV positive rabbit sera against N 
protein (Andersson et.al 2004 J. Med Virol), recombinant CCHFV N protein (Andersson 
et.al 2004 J. Med Virol), anti-CCHFV monoclonal antibody against N protein and anti-
CCHF polyclonal rabbit antibodies were all received from the Public Health Agency of 
Sweden. Human IgG was detected with donkey HRP-coupled anti-human IgG antibodies. 
Rabbit antibodies were detected with HRP-coupled goat anti-rabbit IgG HRP (Jackson 
ImmunoResearch Laboratories, USA). 
 
Optical fiber immobilization 
We used SFS400/440B black Tefzel®Superguide G UV-Vis (Fiberguide Industries, Stirling, 
NJ, USA) optic fibers. The length of any single fiber used in the experiments was 
approximately 25 cm. Tefzel® jacket and silicon buffer were removed with a fiber 
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stripping tool (Micro-Strip®, from Micro-Electronics Inc., MA, USA), leaving a 0.5 cm 
nude optical fiber core tip. 
Optic fibers were prepared according to the reference protocol described by Liebes et 
al.
 14
. Briefly, the fibers were cleaned by sonication in 1:1 (v/v) methanol/ 97% HCl 
solution for 10 min at 90ºC and treated with piranha solution (7:3 [v/v] H2S04/H202) to 
produce surface hydroxyl groups, rinsed with nanopure water and dried with nitrogen 
gas. Fiber surfaces were then silanized with (3-glycidoxypropyl)trimethoxysilane for 60 
min at 90ºC. Fibers were treated with 11.6 mM hydrochloric acid for 60 min (formation 
of vicinal diols) and 100 mM sodium m-periodate dissolved in 10% (v/v) acetic acid for 
60 min at room temperature (oxidation to aldehyde). Fibers were then rinsed with 
deionized water and incubated with 1ml of 0.43µg/ml HRP (for assay optimization) or 
CCHFV NP (for assay validation) overnight at 4ºC. Un-reacted aldehyde groups were 
blocked using 1 M glycine for 30 min at RT and the unsaturated amines were stabilized 
by a Schiff base with 0.3 M sodium cyanoborohydride for 60 min at RT. 
 
Fiber-optic chemiluminescent and Colorimetric immunoassay 
Instrument set-up for chemiluminescence measurements was performed as previously 
described [22, 23]. A Hamamatsu HC135-01 Photo Multiplier Tube (PMT) Sensor Module 
was used for chemiluminescence measurements in a light-tight box. The far end of the 
fiber was held by a fiber holder (FPH-DJ, Newport) and placed into an adjustable single-
fiber mount (77837, Oriel). Real-time data acquisition was performed using LabView 
(version 3.1, National Instruments Corporation). Chemiluminiscence detection was 
performed with the Immuno-star HRP chemiluminescent kit (170-5040, Bio-Rad 
Laboratories, France). Chemiluminescence readings were integrated for 1 s, measuring a 
mean value of photon counts during 15 s. Results are presented as the mean and 
standard deviation of relative light units (RLU). Colorimetric detection was performed 
using 100µl  3,3,5,5-tetramethylbenzidine (TMB) (T0440, Sigma Aldrich, Israel)  and 50µl 
of 2N H2SO4 afterwards in each well. Optical density readings at 450 were determined 
with a Labsystems Multiscan RC ELISA reader. 
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 Protocol optimization 
The initial immobilization protocol (Protocol 1) 
 14
 was optimized in order to achieve 
maximum output chemiluminescence signal levels. For protocol optimization we 
immobilized 200 U/ml HRP on the fiber optic. Optimization steps are shown in Table 1. 
Steps with the highest chemiluminescence output comprise the optimized protocol 
(Protocol 2), which we used for the optic-fibre immobilization with CCHF virus NP. 
We also evaluated the effect of two different HRP substrate compositions. We 
compared the output levels of the Immuno-star-HRPTM substrate (Bio-Rad), that 
includes 1:1 luminol/enhancer and stable peroxide buffer, and a substrate described by 
Vdovdenko et al. 
 15
 that is based on the addition of two enhancers: SPTZ (sodium salt of 
3-(10′-phenothiazinyl)propane-1-sulfonate) and MORP (4-morpholinopyridine). A total 
of 240µl substrate was added to each well. 
 
Fiber-optic immunoassay for detection of CCHF antibodies 
Assay’s sensitivity was evaluated with a 10
2
 to 10
6
 dilution range of Polyclonal Rabbit 
anti-CCHF virus antibodies. Briefly, 200 μl diluted antibodies were added per well (five 
sets of triplicates) and incubated for 60 min. 
Sensitivity of the assay was further evaluated with two confirmed samples from two 
CCHF patients from Turkey. The samples were collected for routine diagnostic purposes 
in Turkey and development of diagnostic tools and their collection was approved by the 
governing ethical committee (Turkish Public Health Institution). Serum samples were 
chosen based on their initial serology results: high-level IgG for patient 1 (CDC ELISA, 
OD: 2) and low-level IgG for patient 2 (OD: 0,4).  
Optic fibers were incubated with 200μl diluted serum (dilutions from 10
3
 to 10
6
) for 
60 min (three sets of triplicates). Unmodified fibers were used to check the level of 
background signal. Optic fiber tips were washed four times with PBST–BSA for a one-
time 10 min, followed by a three time 3 min protocol. Fibers were then dipped into 
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200μl donkey anti-human IgG peroxidase-labeled antibodies (1/500) for 60 mi and 
washed with PBS-Tween before chemiluminiscence detection as described above. 
 
CCHF IgG ELISA  
Fiber-optic immunoassay for detection of CCHF virus antibodies performance was 
compared to the performance of CCHF IgG ELISA. MaxiSorp 96-well microtiter plates 
(Nunc) were coated with 100µl/well of CCHF virus NP. Plates were placed overnight at 
4ºC. Plates were then washed three times with 100µl of PBS each. Each well was 
blocked by 150µl/well of blocking solution (1M glycine (w/v) in PBS buffer, pH 7.2) for 
1 h at 37ºC. Plates were washed three times with 100µl 0.1%PBST containing 5% (w/v) 
skimmed milk (washing step). Serial dilutions (10
-2
-10
-6
) of anti-CCHF antibodies 
(100µL/well) were added in triplicates and incubated for 1 h at 37ºC followed by a 
washing step.  Goat anti-mouse IgG peroxidase-labeled antibodies (100 µl/well) (10
3
) 
were added and incubated for 1 h at 37ºC, followed by a washing step. Two different 
substrates were used. For colorimetric ELISA, we added 3,3',5,5' tetramethylbenzidine 
(TMB) (100 µl/well) and incubated at room temperature for 30 min in the dark. The 
reaction was stopped with 2N H2SO4 (50 µl/well). Optical density reads at 450 nm 
(OD450) were determined with the Labsystems Multiscan RC ELISA reader. Results are 
presented as the mean and standard deviation of OD450.
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Results and Discussion 
The aim of this study was to develop and optimize a fiber optic biosensor for detection 
of CCHF virus antibodies. As a starting point we used a previously described 
immobilization protocol (Protocol 1)
 14
 and optimized each step in order to maximize the 
chemiluminescence output. In the cleaning step we tested the effects of sonication and 
duration of methanol washing. We showed that sonication significantly increased the 
biosensor end point signal output (RLU 6857 vs. 1114 without sonication) and that 
methanol washing for 20 min was the most effective. Next we wanted to assess the 
efficacy of optical fiber activation (production of surface hydroxyl groups) using different 
activating solutions. Namely, we wanted to replace the piranha solution with a safer 
alternative as it is highly toxic and dangerous, requires special handling and disposal 
measures. However, our results show that the piranha solution was by far the most 
effective activator, with the biosensor output of 16669 RLU. Neither HCL, H2SO4, 
CH3COOH or H3PO4 had comparable results (RLU: 3598, 9625, 1991, 5681, respectively). 
Piranha solution was therefore used in the optimized protocol (Protocol 2). Next step 
was the optimization of the silanization process. We tested 3 different temperatures 
(30°C, 60°C and 90°C) and 3 different durations (30 min, 60 min, 90 min) of silanization. 
We obtained the highest biosensor output at 60°C for 60 min (8660 RLU). In the last step 
we optimized the temperature and duration of treatment with sodium m-peroxidate. 
The highest biosensor output was achieved at 25°C for 90 min (20594 RLU). The results 
of the protocol optimization are shown in Table 1. 
Next, we compared protocols 1 and 2 for their overall performance in the immunoassay, 
and as seen in Figure 1, the sensitivity of protocol 2 is 100-fold higher (limit of detection 
for protocol 1 is antibody dilution 10
-4
 and for protocol 2 is 10
-6
). The results show that 
optimization steps had great influence on the overall efficacy of the immunoassay. 
Protocol 2 was therefore used for validation of the fiber-optic biosensor using patient 
sera. 
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We also compared two different substrate formulations with respect to the overall 
biosensor output. We wanted to assess if enhancers (SPTZ or MORP) added to the 
luminol/peroxide substrate, would enhance the biosensor’s output, and indeed, as seen 
in figure 2, the addition of the two enhancers did increase the biosensor’s output by 
roughly 10-fold. An additional advantage in using SPTZ/MORP enhancers is that they 
provide a more durable light signal that increases the biosensor’s sensitivity
16
. 
In the last step we evaluated the sensitivity of the developed fiber-optic biosensor for 
the detection of CCHF IgG antibodies in human sera. We tested the assay with both 
patients’ sera. Fiber-optic biosensor detection was more sensitive than ELISAs. The 
lowest limit of detection of Patient 1 serum was 10-fold greater compared to ELISA, 
down to titer 1:1,000,000. The assay was also able to detect the low positive serum 
sample of Patient 2 down to titer 1:5,000 (Table 2). 
Our results show that our fiber-optic biosensor is a suitable alternative for ELISA, for the 
detection of CCHF virus IgG antibodies. The assay enables rapid and sensitive detection 
of CCHF antibodies and can be manufactured as a semi-disposable, point-of-care device. 
The technology also enables us to modify the device to enable detection of other 
biomolecules (e.g. CCHF RNA). Another advantage of the proposed biosensor is that it 
does not require trained personnel or expensive equipment for its operation. Today’s 
diagnostic assays lack these features and are therefore available only at select 
diagnostic centers. However, the endemic areas of CCHF are mainly rural areas with 
limited access to these high-end diagnostic services. High pathogenicity of CCHF and the 
risk of human-to-human transmissions, especially in hospital settings, warrant the 
development of point-of-care devices that would enable quick, safe and reliable 
diagnostics of CCHF. The main advantage of the fiber optic biosensor is that it provides 
sensitive results and can be designed as a point-of-care device at a cost comparable to 
current standard ELISA assays. The assay could serve as a rapid, primary diagnostic tool 
for bedside CCHF diagnostics in endemic areas where extensive diagnostic equipment 
and trained personnel are not available. The fiber-optic biosensor could provide the 
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necessary solution, however further studies are needed to determine the actual clinical 
sensitivity and specificity of the assay on a larger scale.  
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Table 1: Optimization steps for optical fiber immobilization (in bold are the parameters that define the optimized 
protocol 2) 
Step Optimization 
Biosensor output 
[RLU] 
Cleaning Sonication With 6857 (39.72) 
Without 1114 (15.92) 
Methanol 10 min 4710.17 (24.78) 
20 min 13402.88 (16.86) 
30 min 13141.38 (18.03) 
Activation  HCL 3598 (7.6) 
 Piranha 16669 (31.8) 
 H2SO4 9625 (26.2) 
 CH3COOH 1991 (26.4) 
 H3PO4 5681 (16.34) 
Silanization 30 min 30ºC 1428 (32) 
60ºC 2760 (50) 
90ºC 1644 (33) 
60 min 30ºC 1864 (37) 
60ºC 8660 (17) 
90ºC 2941 (46) 
90 min 30ºC 3797 (28) 
60ºC 4198 (40) 
90ºC 1204 (3) 
Sodium m-
periodate 
30 min 25ºC 1576 (31.5) 
30ºC 1870 (35.9) 
60ºC 1415 (16.4) 
60 min 25ºC 9086 (31.5) 
30ºC 3357 (15.4) 
60ºC 3465 (36.4) 
90 min 25ºC 20594 (18.9) 
30ºC 7884 (33.4) 
60ºC 3626 (26.1) 
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Table 2: Immunoassay results 
Sample Dilution 
Fiber optic 
biosensor  ELISA 
Patient 1 1:5000 + + 
 
1:10000 + + 
 
1:20000 + + 
 
1:50000 + + 
 
1:100000 + + 
 
1:250000 + - 
 
1:500000 + - 
 
1:750000 + - 
 1:1000000 + - 
Patient 2 1:1000 + ND 
 
1:5000 + ND 
 1:10000 - ND 
No serum control 
 
- - 
Human serum control - - 
Rabbit serum control  - - 
Positive control 
 
+ + 
No primary antibody 
 
- - 
No secondary antibody   - - 
    ND not determined 
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 Figure 1: Immunoassay results for the comparison of immobilization protocols 1 and 2. 
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 Figure 2: Immunoassay results for the comparison of two substrate formulations. Substrate A is a commercial 
luminol/peroxide formulation, substrate B includes two additional enhancers, SPTZ and MORP. NC= negative 
control. 
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